Predictive model of hyperinflammation in patients with COVID-19
Keywords:
COVID-19, electrical bioimpedance, biomarkers, hyperinflammationAbstract
Introduction: Most severe cases of COVID-19 are associated with hyperinflammation. The scales developed in the context of the recent pandemic have not focused on determining its onset, but rather primarily on prognosis. Early prediction of this disorder is crucial for implementing measures to minimize complications from the disease.
Objective: Design a model for the early prediction of hyperinflammation in patients with COVID‑19.
Methods: An observational, analytical, cohort study was conducted from July 1 to October 31, 2021, at the “Dr. Joaquín Castillo Duany” Military Hospital in Santiago de Cuba; 472 patients were studied. A multivariate analysis was performed using binary logistic regression.
Results: Male patients predominated (72.0%); 27.1% of infected patients took > 3 days to reach the hospital, and the majority were discharged alive (75.0%). In the multivariate analysis, the arterial oxygen pressure/fractional inspired oxygen ratio, phase angle, lactodehydrogenase, taking more than 3 days to reach the hospital, and age ≥ 70 years were significantly related to hyperinflammation. The constructed model showed an area under the curve of 0.930; (95% CI: 0.896–0.954), the Hosmer-Lemeshow test had a value of 0.150 and the Nagelkerke R2 was 0.713.
Conclusions: The predictive model designed from clinical, humoral, hemogasometric and bioelectrical elements showed good fit and discriminatory power.
Downloads
References
1. Silva JA, Ribeiro LR, Gouveia IM, Marcelino DR, Santos SD, Lima VB, et al. Hyperinflammatory Response in COVID-19: A Systematic Review Viruses [Internet]. 2023; 15(2):553. DOI: 10.3390/v15020553
2. Xaverius HPF, Louise FJ, Driessen L, de Smet V, Slingerland-Boot R, Mensink M. Association of bioelectric impedance analysis body composition and disease severity in COVID-19 hospital ward and ICU patients: The BIAC-19 study [Internet]. Clinic Nutrit. 2021 [acceso: 08/08/2024]; 4:2328-36. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7577288
3. Osuna IA, Rodríguez S, Casas GA, Hernández CM, Rodríguez NC, Aguilar A, et al. Low phase angle is associated with 60-day mortality in critically ill patients with COVID-19 [Internet]. J Parenter Enteral Nutr. 2021; 46(4):828-35. DOI: 10.1002/jpen.2236
4. Carriel J, Muñoz R, Bolaños O, Heredia F, Menéndez J, Martin J. CURB-65 como predictor de mortalidad a 30 días en pacientes hospitalizados con COVID-19 en Ecuador: estudio COVID-EC [Internet]. Rev Clin Esp. 2022; 222(1): 37-41. DOI: 10.1016/j.rce.2020.10.001
5. Ministerio de Salud Pública de Cuba. Protocolo de actuación nacional para la COVID-19. Versión 1.6 [Internet]. La Habana: Ministerio de salud pública; 2021. [acceso: 24/05/2025]. Disponible en: https://covid19cubadata.github.io/protocolos/protocolo-version-6.pdf
6. Cardozo S, Sanabria O. Índices de oxigenación: más allá de la PaO2/FiO2 como herramienta ideal [Internet]. Acta colomb cuid intensiv. 2022 [acceso: 21/06/2025]; 22(3): 227-36. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0122726222000246
7. Chávez CA. Predictor del deterioro de mecánica pulmonar a través de elevación de índice oxigenatorio y disminución del Pao2/Fio2 en pacientes con infección por COVID-19 que cursan con síndrome de distrés respiratorio agudo [Internet]. [Tesis de especialidad]. Perú: Universidad Científica del Sur; 2021. [acceso: 21/06/2025]. Disponible en: https://repositorio.cientifica.edu.pe/handle/20.500.12805/2393
8. Patiño MV, Yaro CR. Correlación entre los índices SpO2/FiO2 y PaO2/FiO2 en SDRA ocasionado por SARS-COV-2 en residentes de gran altitud del Hospital Nacional Ramiro Prialé [Internet]. [Tesis de especialista]. Huancayo: Facultad de Ciencias de la Salud; 2023. [acceso: 21/06/2025]. Disponible en: https://repositorio.continental.edu.pe/handle/20.500.12394/12872
9. Belenguer A, Bernal F, Hernández H, Hermosilla I, Tormo L, Viana C. Correlation and concordance of SaO2/FiO2 and PaO2/FiO2 ratios in patients with COVID-19 pneumonia who received non-invasive ventilation in two intensive care units [Internet]. Med intensiva. 2024 [acceso:11/02/2025];48(5):298-300. Disponible en: https://www.medintensiva.org/en-pdf-S2173572724000444
10. Chen IY, Moriyama M, Chang MF, Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome [Internet]. Front Microbiol. 2019; 10:1-9. DOI: 10.3389/fmicb.2019.00050
11. González R, Acosta FA, Oliva E, Rodríguez SF, Cabeza I. Predictores de mal pronóstico en pacientes con la COVID-19 [Internet]. Rev Cubana Med Milit. 2020 [acceso: 14/02/2025]; 49(4):e0200918. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572020000400020
12. Guerrero THE, Gómez GMN, Hernández PAE, Jiménez CC. De lo complejo a lo simple, deshidrogenasa láctica como marcador de severidad en pacientes con infección por SARS-CoV-2 [Internet]. Med Crit. 2021; 35(6):319-28. DOI: 10.35366/103718
13. Cornejo I, Vegas IM, Fernández R, García C, Bellid D, Tinahones F. Phase angle and COVID-19: A systematic review with meta-analysis [Internet]. Rev Endocr Metab Disord. 2023; 24(3):525-42. DOI: 10.1007/s11154-023-09793-6
14. Ferrer JE, del Río G, Amaro I, Benítez E. Ángulo de fase en un modelo predictivo de mortalidad en pacientes con la COVID-19 [Internet]. MEDISAN. 2024 [acceso: 23/03/2025]; 28(5): e4862 Disponible en: https://medisan.sld.cu/index.php/san/article/view/4862
15. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series [Internet]. BMJ Med. 2020 [acceso: 04/06/2025]; 19:368.1-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224340/
16. Pérez MA, Valdés J, Ortiz L. Características clínicas y gravedad de COVID-19 en adultos mexicanos [Internet]. Gac Méd Méx. 2020 [acceso: 04/06/2025];156(5):379-87. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S001638132020000500379&lng=es
17. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty [Internet]. Nat Rev Cardiol. 2018 [acceso: 26/04/2025];15(9):505-22. DOI: 10.1038/s41569-018-0064-2
18. Tafur LA, Rosero AS, Remolina SA, del Mar M, Lema E, Zorrilla A, et al. Características y desenlaces clínicos de pacientes con COVID-19 en la primera ola en Cali, Colombia [Internet]. Acta colomb cuid intensiv. 2022 [acceso: 04/01/2025]; 22(1): 536-45. DOI. 10.1016/j.acci.2021.12.002
19. Herrera CE, Lage A, Betancourt J, Barreto E, Sanchez L, Hernández L. La edad como variable asociada a la gravedad en pacientes con la COVID-19 [Internet]. Rev Cubana Med Milit. 2022 [acceso: 26/01/2025]; 51(1):1-15. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1766
20. León JL, Calderón M, Gutiérrez A. Análisis de mortalidad y comorbilidad por Covid-19 en Cuba. Rev Cubana Med [Internet]. 2021 [acceso: 29/09/2022]; 60(2): 1-11. [aprox. 17 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232021000200004
21. Ramos da Silva B, MialichMS, Cruz LP, Rufato S, Gozzo T, Jordao AA. Performance of functionality measures and phase angle in women exposed to chemotherapy for early breast cancer [Internet]. Clin Nutr ESPEN. 2021; 42:105-16. DOI: 10.1016/j.clnesp.2021.02.007
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jacno Erik Ferrer Castro, Germán del Río Caballero, Irlán Amaro Guerra, Edgar Benítez Sánchez, Zahilyn Rodríguez González

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.